scholarly journals Complete Pathologic Response of Multiple Liver Metastases and Clinical Complete Response of Rectal Cancer in a Patient with Ataxia-Telangiectasia Mutated Gene Mutations After XELOXIRI Plus Bevacizumab: A Case Report

2021 ◽  
Vol Volume 14 ◽  
pp. 4201-4209
Author(s):  
Yu Cheng ◽  
Gang Wu ◽  
Simeng Zhang ◽  
Yunpeng Liu ◽  
Jinglei Qu ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Case Report ◽  
Liver Metastases ◽  
Ataxia Telangiectasia ◽  
Gene Mutations ◽  
Complete Response ◽  
Pathologic Response ◽  
Complete Pathologic Response ◽  
Ataxia Telangiectasia Mutated ◽  
Multiple Liver Metastases

scholarly journals Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Sachie Omori ◽  
Noboru Harada ◽  
Takeo Toshima ◽  
Kazuki Takeishi ◽  
Shinji Itoh ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Case Report ◽  
Liver Metastases ◽  
Neuroendocrine Tumor ◽  
Double Cancer ◽  
Multiple Liver Metastases

scholarly journals Complete Response of Liver Metastasis of Gastric Cancer Treated by S-1 Chemoradiotherapy: A Case Report

2012 ◽  
Vol 2012 ◽  
pp. 1-3 ◽  
Author(s):  
Tomonori Miyazawa ◽  
Kazuyu Ebe ◽  
Norihiko Koide ◽  
Nobuhiro Fujita
Keyword(s):  
Gastric Cancer ◽  
Computed Tomography ◽  
Radiation Therapy ◽  
Case Report ◽  
Liver Metastasis ◽  
Liver Metastases ◽  
Distal Gastrectomy ◽  
Complete Response ◽  
Complete Disappearance ◽  
Multiple Liver Metastases

This paper presents a case of suspected liver metastasis of gastric cancer and a virtual complete response to S-1 chemoradiotherapy. A 69-year-old man underwent distal gastrectomy for gastric cancer in 2008. Multiple liver metastases occurred in 2009. He underwent 15 courses of S-1 therapy and radiation therapy (37.5 Gy). Abdominal computed tomography showed virtual complete disappearance of liver metastasis after chemoradiotherapy. Hence, this case was interpreted as a complete response. No sign of recurrence was noted 18 months after complete response was confirmed. S-1 chemoradiotherapy is likely to be effective in treating patients with liver metastases of gastric cancer.

scholarly journals CIC-DUX4 rearranged uterine cervix round-cell sarcoma exhibiting near-complete pathologic response following radiation and neoadjuvant chemotherapy: A case report

2021 ◽  
Vol 36 ◽  
pp. 100745
Author(s):  
Aline Cristini Vieira ◽  
Camila Bragança Xavier ◽  
Thiago Dieb Vieira ◽  
Filomena Marino Carvalho ◽  
Mariana Scaranti ◽  
...  
Keyword(s):  
Case Report ◽  
Neoadjuvant Chemotherapy ◽  
Uterine Cervix ◽  
Pathologic Response ◽  
Complete Pathologic Response ◽  
Round Cell ◽  
Cell Sarcoma

scholarly journals Pathologic validation of an yttrium-90 trans-arterial radioembolization dosimetry: a case report

2021 ◽  
Vol 2021 (4) ◽  
Author(s):  
Jacqueline B Baikovitz ◽  
Lindsay Thornton ◽  
Monica T Garcia-Buitrago ◽  
Alan S Livingstone ◽  
Matthew T Studenski ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Case Report ◽  
Liver Resection ◽  
Pathologic Response ◽  
Clinical Scenario ◽  
Complete Pathologic Response ◽  
Pathological Findings ◽  
Rigorous Approach ◽  
Yttrium 90

Abstract Yttrium-90 (Y-90) trans-arterial radioembolization (TARE) is used in the management of unresectable hepatocellular carcinoma (HCC). During the last 5 years, dosimetry software has been developed to allow for a more rigorous approach of dose prescription in Y-90 TARE. We present here a case study of a 77-year-old woman diagnosed with HCC, who underwent a Y-90 TARE as a bridge procedure to liver resection. This clinical scenario represents a unique opportunity to illustrate the predictive value of dosimetric findings correlating dosimetry with pathological findings. In this case, Y-90 TARE dosimetry was predictive of treatment response in which the tumor received a mean dose of 156 Gy and demonstrated a complete pathologic response.

Sign in / Sign up

Export Citation Format

Share Document